Search

everythinglearnresearchcommunity

for

Search:↓

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

MLPH helps hair grow by activating IGF-1 signaling in hair cells.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Nanotechnology can improve tissue healing by controlling immune responses.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Prevelex, a polyampholyte, can create a cell-repellent coating on microdevices, which can be useful in biomedical applications like hair follicle regeneration.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.